BRCA1 and Familial prostate cancer: Compared to men with a BRCA1 mutation, men with a BRCA2 mutation in this study were more than two times as likely to die (of any cause) following the diagnosis of prostate cancer (hazard ratio 2.5), and it is likely that the relative mortality for prostate cancer-specific mortality would be even more extreme.